{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:01:15Z","timestamp":1784325675415,"version":"3.55.0"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-025-10539-6","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T07:56:43Z","timestamp":1750492603000},"page":"1191-1205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Skeletal muscle atrophy in pulmonary arterial hypertension: potential mechanisms and effects of physical exercise"],"prefix":"10.1007","volume":"30","author":[{"given":"Sebasti\u00e3o Felipe Ferreira","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le\u00f4ncio Lopes","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano Bernardes","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Martins Oliveira","family":"Portes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio Jos\u00e9","family":"Natali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"key":"10539_CR1","doi-asserted-by":"publisher","first-page":"220168","DOI":"10.1183\/20734735.0168-2022","volume":"18","author":"S Cullivan","year":"2022","unstructured":"Cullivan S, Higgins M, Gaine S (2022) Diagnosis and management of pulmonary arterial hypertension. Breathe 18:220168. https:\/\/doi.org\/10.1183\/20734735.0168-2022","journal-title":"Breathe"},{"key":"10539_CR2","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M et al (2022) ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS). Endorsed by the international society for heart and lung transplantation (ISHLT) and the European reference network on rare respiratory diseases (ERN-LUNG). Eur Heart J 43:3618\u20133731. https:\/\/doi.org\/10.1093\/eurheartj\/ehac237","journal-title":"Eur Heart J"},{"key":"10539_CR3","doi-asserted-by":"publisher","unstructured":"Thenappan T, Ormiston ML, Ryan JJ, Archer SL (2018) Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ j5492. https:\/\/doi.org\/10.1136\/bmj.j5492","DOI":"10.1136\/bmj.j5492"},{"key":"10539_CR4","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1378\/chest.08-0492","volume":"135","author":"HJ Bogaard","year":"2009","unstructured":"Bogaard HJ, Abe K, Vonk Noordegraaf A, Voelkel NF (2009) The right ventricle under pressure. Chest 135:794\u2013804. https:\/\/doi.org\/10.1378\/chest.08-0492","journal-title":"Chest"},{"key":"10539_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1183\/09059180.00007414","volume":"23","author":"R Naeije","year":"2014","unstructured":"Naeije R, Manes A (2014) The right ventricle in pulmonary arterial hypertension. Eur Respir Rev 23:476\u2013487. https:\/\/doi.org\/10.1183\/09059180.00007414","journal-title":"Eur Respir Rev"},{"key":"10539_CR6","doi-asserted-by":"publisher","first-page":"641310","DOI":"10.3389\/fphys.2021.641310","volume":"12","author":"D Sharifi Kia","year":"2021","unstructured":"Sharifi Kia D, Kim K, Simon MA (2021) Current understanding of the right ventricle structure and function in pulmonary arterial hypertension. Front Physiol 12:641310. https:\/\/doi.org\/10.3389\/fphys.2021.641310","journal-title":"Front Physiol"},{"key":"10539_CR7","doi-asserted-by":"publisher","first-page":"2102334","DOI":"10.1183\/13993003.02334-2021","volume":"59","author":"R Naeije","year":"2022","unstructured":"Naeije R, Richter MJ, Rubin LJ (2022) The physiological basis of pulmonary arterial hypertension. Eur Respir J 59:2102334. https:\/\/doi.org\/10.1183\/13993003.02334-2021","journal-title":"Eur Respir J"},{"key":"10539_CR8","doi-asserted-by":"publisher","first-page":"e12135","DOI":"10.1002\/pul2.12135","volume":"12","author":"LA Matura","year":"2022","unstructured":"Matura LA, Fargo JD, Boyle K, Fritz JS, Smith KA, Mazurek JA et al (2022) Symptom phenotypes in pulmonary arterial hypertension: the PAH \u201csymptome.\u201d Pulm Circ 12:e12135. https:\/\/doi.org\/10.1002\/pul2.12135","journal-title":"Pulm Circ"},{"key":"10539_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12931-016-0388-6","volume":"17","author":"D McCollister","year":"2016","unstructured":"McCollister D, Shaffer S, Badesch DB, Filusch A, Hunsche E, Sch\u00fcler R et al (2016) Development of the pulmonary arterial hypertension-symptoms and impact (PAH-SYMPACT\u00ae) questionnaire: a new patient-reported outcome instrument for PAH. Respir Res 17:72. https:\/\/doi.org\/10.1186\/s12931-016-0388-6","journal-title":"Respir Res"},{"key":"10539_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/359204","volume":"2012","author":"RM Fowler","year":"2012","unstructured":"Fowler RM, Gain KR, Gabbay E (2012) Exercise intolerance in pulmonary arterial hypertension. Pulmonary Med 2012:1\u201310. https:\/\/doi.org\/10.1155\/2012\/359204","journal-title":"Pulmonary Med"},{"key":"10539_CR11","doi-asserted-by":"publisher","first-page":"200284","DOI":"10.1183\/16000617.0284-2020","volume":"30","author":"S Malenfant","year":"2021","unstructured":"Malenfant S, Lebret M, Breton-Gagnon \u00c9, Potus F, Paulin R, Bonnet S et al (2021) Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms. Eur Respir Rev 30:200284. https:\/\/doi.org\/10.1183\/16000617.0284-2020","journal-title":"Eur Respir Rev"},{"key":"10539_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1164\/rccm.201402-0383OC","volume":"190","author":"F Potus","year":"2014","unstructured":"Potus F, Malenfant S, Graydon C, Mainguy V, Tremblay \u00c8, Breuils-Bonnet S et al (2014) Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension. Am J Respir Crit Care Med 190:318\u2013328. https:\/\/doi.org\/10.1164\/rccm.201402-0383OC","journal-title":"Am J Respir Crit Care Med"},{"key":"10539_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1152\/physiol.00041.2007","volume":"23","author":"M Sandri","year":"2008","unstructured":"Sandri M (2008) Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 23:160\u2013170. https:\/\/doi.org\/10.1152\/physiol.00041.2007","journal-title":"Physiology (Bethesda)"},{"key":"10539_CR14","doi-asserted-by":"publisher","first-page":"105807","DOI":"10.1016\/j.phrs.2021.105807","volume":"172","author":"L Yin","year":"2021","unstructured":"Yin L, Li N, Jia W, Wang N, Liang M, Yang X et al (2021) Skeletal muscle atrophy: from mechanisms to treatments. Pharmacol Res 172:105807. https:\/\/doi.org\/10.1016\/j.phrs.2021.105807","journal-title":"Pharmacol Res"},{"key":"10539_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1242\/dmm.010389","volume":"6","author":"P Bonaldo","year":"2013","unstructured":"Bonaldo P, Sandri M (2013) Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech 6:25\u201339. https:\/\/doi.org\/10.1242\/dmm.010389","journal-title":"Dis Model Mech"},{"key":"10539_CR16","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.biocel.2013.04.023","volume":"45","author":"M Sandri","year":"2013","unstructured":"Sandri M (2013) Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome. Int J Biochem Cell Biol 45:2121\u20132129. https:\/\/doi.org\/10.1016\/j.biocel.2013.04.023","journal-title":"Int J Biochem Cell Biol"},{"key":"10539_CR17","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41467-020-20123-1","volume":"12","author":"R Sartori","year":"2021","unstructured":"Sartori R, Romanello V, Sandri M (2021) Mechanisms of muscle atrophy and hypertrophy: implications in health and disease. Nat Commun 12:330. https:\/\/doi.org\/10.1038\/s41467-020-20123-1","journal-title":"Nat Commun"},{"key":"10539_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nrd4467","volume":"14","author":"S Cohen","year":"2015","unstructured":"Cohen S, Nathan JA, Goldberg AL (2015) Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov 14:58\u201374. https:\/\/doi.org\/10.1038\/nrd4467","journal-title":"Nat Rev Drug Discov"},{"key":"10539_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jshs.2023.04.001","volume":"12","author":"H Gallagher","year":"2023","unstructured":"Gallagher H, Hendrickse PW, Pereira MG, Bowen TS (2023) Skeletal muscle atrophy, regeneration, and dysfunction in heart failure: impact of exercise training. J Sport Health Sci 12:557\u2013567. https:\/\/doi.org\/10.1016\/j.jshs.2023.04.001","journal-title":"J Sport Health Sci"},{"key":"10539_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1253\/circj.CJ-12-1235","volume":"77","author":"K Okita","year":"2013","unstructured":"Okita K, Kinugawa S, Tsutsui H (2013) Exercise intolerance in chronic heart failure: \u2013 skeletal muscle dysfunction and potential therapies \u2013. Circ J 77:293\u2013300. https:\/\/doi.org\/10.1253\/circj.CJ-12-1235","journal-title":"Circ J"},{"key":"10539_CR21","doi-asserted-by":"publisher","unstructured":"Rutledge CA (2024) Molecular mechanisms underlying sarcopenia in heart failure. J Cardiovasc Aging 4. https:\/\/doi.org\/10.20517\/jca.2023.40","DOI":"10.20517\/jca.2023.40"},{"key":"10539_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1536\/ihj.15-108","volume":"56","author":"S Kinugawa","year":"2015","unstructured":"Kinugawa S, Takada S, Matsushima S, Okita K, Tsutsui H (2015) Skeletal muscle abnormalities in heart failure. Int Heart J 56:475\u2013484. https:\/\/doi.org\/10.1536\/ihj.15-108","journal-title":"Int Heart J"},{"key":"10539_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1165\/rcmb.2012-0506OC","volume":"50","author":"J Batt","year":"2014","unstructured":"Batt J, Ahmed SS, Correa J, Bain A, Granton J (2014) Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol 50:74\u201386. https:\/\/doi.org\/10.1165\/rcmb.2012-0506OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10539_CR24","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1016\/j.bbadis.2015.10.002","volume":"1852","author":"D Moreira-Gon\u00e7alves","year":"2015","unstructured":"Moreira-Gon\u00e7alves D, Padr\u00e3o AI, Ferreira R, Justino J, Nogueira-Ferreira R, Neuparth MJ et al (2015) Signaling pathways underlying skeletal muscle wasting in experimental pulmonary arterial hypertension. Biochimica et Biophys Acta (BBA) - Mol Basis Dis 1852:2722\u201331. https:\/\/doi.org\/10.1016\/j.bbadis.2015.10.002","journal-title":"Biochimica et Biophys Acta (BBA) - Mol Basis Dis"},{"key":"10539_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/thx.2009.117168","volume":"65","author":"V Mainguy","year":"2010","unstructured":"Mainguy V, Maltais F, Saey D, Gagnon P, Martel S, Simon M et al (2010) Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax 65:113\u2013117. https:\/\/doi.org\/10.1136\/thx.2009.117168","journal-title":"Thorax"},{"key":"10539_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/thoraxjnl-2017-211440","volume":"74","author":"BE Garfield","year":"2019","unstructured":"Garfield BE, Crosby A, Shao D, Yang P, Read C, Sawiak S et al (2019) Growth\/differentiation factor 15 causes TGF\u03b2-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertension. Thorax 74:164\u2013176. https:\/\/doi.org\/10.1136\/thoraxjnl-2017-211440","journal-title":"Thorax"},{"key":"10539_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13395-022-00292-x","volume":"12","author":"G Xiang","year":"2022","unstructured":"Xiang G, Ying K, Jiang P, Jia M, Sun Y, Li S et al (2022) Growth differentiation factor 11 induces skeletal muscle atrophy via a STAT3-dependent mechanism in pulmonary arterial hypertension. Skeletal Muscle 12:10. https:\/\/doi.org\/10.1186\/s13395-022-00292-x","journal-title":"Skeletal Muscle"},{"key":"10539_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev.biochem.78.081507.101607","volume":"78","author":"D Finley","year":"2009","unstructured":"Finley D (2009) Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 78:477\u2013513. https:\/\/doi.org\/10.1146\/annurev.biochem.78.081507.101607","journal-title":"Annu Rev Biochem"},{"key":"10539_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0955-0674(95)80031-x","volume":"7","author":"M Hochstrasser","year":"1995","unstructured":"Hochstrasser M (1995) Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol 7:215\u2013223. https:\/\/doi.org\/10.1016\/0955-0674(95)80031-x","journal-title":"Curr Opin Cell Biol"},{"key":"10539_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12576-020-00768-9","volume":"70","author":"Y Kitajima","year":"2020","unstructured":"Kitajima Y, Yoshioka K, Suzuki N (2020) The ubiquitin\u2013proteasome system in regulation of the skeletal muscle homeostasis and atrophy: from basic science to disorders. J Physiol Sci 70:40. https:\/\/doi.org\/10.1186\/s12576-020-00768-9","journal-title":"J Physiol Sci"},{"key":"10539_CR31","doi-asserted-by":"publisher","first-page":"1402639","DOI":"10.3389\/fmed.2024.1402639","volume":"11","author":"C Ejikeme","year":"2024","unstructured":"Ejikeme C, Safdar Z (2024) Exploring the pathogenesis of pulmonary vascular disease. Front Med 11:1402639. https:\/\/doi.org\/10.3389\/fmed.2024.1402639","journal-title":"Front Med"},{"key":"10539_CR32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.pcad.2012.07.006","volume":"55","author":"H El Chami","year":"2012","unstructured":"El Chami H, Hassoun PM (2012) Immune and inflammatory mechanisms in pulmonary arterial hypertension. Prog Cardiovasc Dis 55:218\u2013228. https:\/\/doi.org\/10.1016\/j.pcad.2012.07.006","journal-title":"Prog Cardiovasc Dis"},{"key":"10539_CR33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/978-3-030-63046-1_15","volume":"1303","author":"S Liang","year":"2021","unstructured":"Liang S, Desai AA, Black SM, Tang H (2021) Cytokines, chemokines, and inflammation in pulmonary arterial hypertension. Adv Exp Med Biol 1303:275\u2013303. https:\/\/doi.org\/10.1007\/978-3-030-63046-1_15","journal-title":"Adv Exp Med Biol"},{"key":"10539_CR34","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.109.933762","volume":"122","author":"E Soon","year":"2010","unstructured":"Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD et al (2010) Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 122:920\u2013927. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.933762","journal-title":"Circulation"},{"key":"10539_CR35","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.116.022362","volume":"141","author":"S Rosenkranz","year":"2020","unstructured":"Rosenkranz S, Howard LS, Gomberg-Maitland M, Hoeper MM (2020) Systemic consequences of pulmonary hypertension and right-sided heart failure. Circulation 141:678\u2013693. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.022362","journal-title":"Circulation"},{"key":"10539_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/rr67","volume":"2","author":"MB Reid","year":"2001","unstructured":"Reid MB, Li Y-P (2001) Tumor necrosis factor-\u03b1 and muscle wasting: a cellular perspective. Respir Res 2:269. https:\/\/doi.org\/10.1186\/rr67","journal-title":"Respir Res"},{"key":"10539_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cyto.2011.01.009","volume":"54","author":"BJN Sishi","year":"2011","unstructured":"Sishi BJN, Engelbrecht A-M (2011) Tumor necrosis factor alpha (TNF-\u03b1) inactivates the PI3-kinase\/PKB pathway and induces atrophy and apoptosis in L6 myotubes. Cytokine 54:173\u2013184. https:\/\/doi.org\/10.1016\/j.cyto.2011.01.009","journal-title":"Cytokine"},{"key":"10539_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","volume":"16","author":"T Setiawan","year":"2023","unstructured":"Setiawan T, Sari IN, Wijaya YT, Julianto NM, Muhammad JA, Lee H et al (2023) Cancer cachexia: molecular mechanisms and treatment strategies. J Hematol Oncol 16:54. https:\/\/doi.org\/10.1186\/s13045-023-01454-0","journal-title":"J Hematol Oncol"},{"key":"10539_CR39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1165\/rcmb.2019-0431OC","volume":"64","author":"D Yerabolu","year":"2021","unstructured":"Yerabolu D, Weiss A, Kojonazarov B, Boehm M, Schlueter BC, Ruppert C et al (2021) Targeting Jak-Stat signaling in experimental pulmonary hypertension. Am J Respir Cell Mol Biol 64:100\u2013114. https:\/\/doi.org\/10.1165\/rcmb.2019-0431OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10539_CR40","doi-asserted-by":"publisher","first-page":"7814","DOI":"10.1002\/jcp.30394","volume":"236","author":"W Lei","year":"2021","unstructured":"Lei W, Liu D, Sun M, Lu C, Yang W, Wang C et al (2021) Targeting STAT3: a crucial modulator of sepsis. J Cell Physiol 236:7814\u20137831. https:\/\/doi.org\/10.1002\/jcp.30394","journal-title":"J Cell Physiol"},{"key":"10539_CR41","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C (2017) NF-\u03baB signaling in inflammation. Sig Transduct Target Ther 2:17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23","journal-title":"Sig Transduct Target Ther"},{"key":"10539_CR42","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/978-981-13-1435-3_12","volume-title":"Muscle atrophy","author":"A Thoma","year":"2018","unstructured":"Thoma A, Lightfoot AP (2018) NF-kB and inflammatory cytokine signalling: role in skeletal muscle atrophy. In: Xiao J (ed) Muscle atrophy, vol 1088. Singapore, Springer Singapore, pp 267\u201379. https:\/\/doi.org\/10.1007\/978-981-13-1435-3_12"},{"key":"10539_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.bbrc.2012.12.105","volume":"431","author":"F Gao","year":"2013","unstructured":"Gao F, Kishida T, Ejima A, Gojo S, Mazda O (2013) Myostatin acts as an autocrine\/paracrine negative regulator in myoblast differentiation from human induced pluripotent stem cells. Biochem Biophys Res Commun 431:309\u2013314. https:\/\/doi.org\/10.1016\/j.bbrc.2012.12.105","journal-title":"Biochem Biophys Res Commun"},{"key":"10539_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/387083a0","volume":"387","author":"AC McPherron","year":"1997","unstructured":"McPherron AC, Lawler AM, Lee S-J (1997) Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member. Nature 387:83\u201390. https:\/\/doi.org\/10.1038\/387083a0","journal-title":"Nature"},{"key":"10539_CR45","doi-asserted-by":"publisher","first-page":"40235","DOI":"10.1074\/jbc.M004356200","volume":"275","author":"M Thomas","year":"2000","unstructured":"Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J et al (2000) Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275:40235\u201340243. https:\/\/doi.org\/10.1074\/jbc.M004356200","journal-title":"J Biol Chem"},{"key":"10539_CR46","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00018-022-04408-w","volume":"79","author":"E Abati","year":"2022","unstructured":"Abati E, Manini A, Comi GP, Corti S (2022) Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases. Cell Mol Life Sci 79:374. https:\/\/doi.org\/10.1007\/s00018-022-04408-w","journal-title":"Cell Mol Life Sci"},{"key":"10539_CR47","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1378\/chest.11-0793","volume":"141","author":"LC Price","year":"2012","unstructured":"Price LC, Wort SJ, Perros F, Dorfm\u00fcller P, Huertas A, Montani D et al (2012) Inflammation in pulmonary arterial hypertension. Chest 141:210\u2013221. https:\/\/doi.org\/10.1378\/chest.11-0793","journal-title":"Chest"},{"key":"10539_CR48","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.cmet.2013.07.012","volume":"18","author":"L Zhang","year":"2013","unstructured":"Zhang L, Pan J, Dong Y, Tweardy DJ, Dong Y, Garibotto G et al (2013) Stat3 activation links a C\/EBP\u03b4 to myostatin pathway to stimulate loss of muscle mass. Cell Metab 18:368\u2013379. https:\/\/doi.org\/10.1016\/j.cmet.2013.07.012","journal-title":"Cell Metab"},{"key":"10539_CR49","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1083\/jcb.200707179","volume":"180","author":"N Bakkar","year":"2008","unstructured":"Bakkar N, Wang J, Ladner KJ, Wang H, Dahlman JM, Carathers M et al (2008) IKK\/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J Cell Biol 180:787\u2013802. https:\/\/doi.org\/10.1083\/jcb.200707179","journal-title":"J Cell Biol"},{"key":"10539_CR50","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s13539-011-0035-5","volume":"2","author":"Y Elkina","year":"2011","unstructured":"Elkina Y, Von Haehling S, Anker SD, Springer J (2011) The role of myostatin in muscle wasting: an overview. J Cachexia Sarcopenia Muscle 2:143\u2013151. https:\/\/doi.org\/10.1007\/s13539-011-0035-5","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10539_CR51","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","volume":"289","author":"DC Guttridge","year":"2000","unstructured":"Guttridge DC, Mayo MW, Madrid LV, Wang C-Y, Baldwin AS Jr (2000) NF-\u03baB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289:2363\u20132366. https:\/\/doi.org\/10.1126\/science.289.5488.2363","journal-title":"Science"},{"key":"10539_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.afos.2023.03.008","volume":"9","author":"A Mitra","year":"2023","unstructured":"Mitra A, Qaisar R, Bose B, Sudheer SP (2023) The elusive role of myostatin signaling for muscle regeneration and maintenance of muscle and bone homeostasis. Osteoporosis Sarcopenia 9:1\u20137. https:\/\/doi.org\/10.1016\/j.afos.2023.03.008","journal-title":"Osteoporosis Sarcopenia"},{"key":"10539_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/925350","volume":"2014","author":"Y Wang","year":"2014","unstructured":"Wang Y, Zhou Y, Graves DT (2014) FOXO transcription factors: their clinical significance and regulation. Biomed Res Int 2014:1\u201313. https:\/\/doi.org\/10.1155\/2014\/925350","journal-title":"Biomed Res Int"},{"key":"10539_CR54","doi-asserted-by":"publisher","first-page":"11611","DOI":"10.3390\/ijms231911611","volume":"23","author":"M Marchelek-Mysliwiec","year":"2022","unstructured":"Marchelek-Mysliwiec M, Nalewajska M, Turo\u0144-Skrzypi\u0144ska A, Kotrych K, Dziedziejko V, Sulikowski T et al (2022) The role of forkhead box O in pathogenesis and therapy of diabetes mellitus. IJMS 23:11611. https:\/\/doi.org\/10.3390\/ijms231911611","journal-title":"IJMS"},{"key":"10539_CR55","doi-asserted-by":"publisher","first-page":"1179101","DOI":"10.3389\/fimmu.2023.1179101","volume":"14","author":"J Lees","year":"2023","unstructured":"Lees J, Hay J, Moles MW, Michie AM (2023) The discrete roles of individual FOXO transcription factor family members in B-cell malignancies. Front Immunol 14:1179101. https:\/\/doi.org\/10.3389\/fimmu.2023.1179101","journal-title":"Front Immunol"},{"key":"10539_CR56","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41419-023-06177-1","volume":"14","author":"BF Santos","year":"2023","unstructured":"Santos BF, Grenho I, Martel PJ, Ferreira BI, Link W (2023) FOXO family isoforms. Cell Death Dis 14:702. https:\/\/doi.org\/10.1038\/s41419-023-06177-1","journal-title":"Cell Death Dis"},{"key":"10539_CR57","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1038\/ncomms7670","volume":"6","author":"G Milan","year":"2015","unstructured":"Milan G, Romanello V, Pescatore F, Armani A, Paik J-H, Frasson L et al (2015) Regulation of autophagy and the ubiquitin\u2013proteasome system by the FoxO transcriptional network during muscle atrophy. Nat Commun 6:6670. https:\/\/doi.org\/10.1038\/ncomms7670","journal-title":"Nat Commun"},{"key":"10539_CR58","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.ajpath.2022.09.003","volume":"192","author":"K Chen","year":"2022","unstructured":"Chen K, Gao P, Li Z, Dai A, Yang M, Chen S et al (2022) Forkhead box O signaling pathway in skeletal muscle atrophy. Am J Pathol 192:1648\u20131657. https:\/\/doi.org\/10.1016\/j.ajpath.2022.09.003","journal-title":"Am J Pathol"},{"key":"10539_CR59","doi-asserted-by":"publisher","first-page":"100903","DOI":"10.1016\/j.jbior.2022.100903","volume":"85","author":"N Vilchinskaya","year":"2022","unstructured":"Vilchinskaya N, Altaeva E, Lomonosova Y (2022) Gaining insight into the role of FoxO1 in the progression of disuse-induced skeletal muscle atrophy. Adv Biol Regul 85:100903. https:\/\/doi.org\/10.1016\/j.jbior.2022.100903","journal-title":"Adv Biol Regul"},{"key":"10539_CR60","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4161\/auto.5905","volume":"4","author":"C Mammucari","year":"2008","unstructured":"Mammucari C, Schiaffino S, Sandri M (2008) Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle. Autophagy 4:524\u2013526. https:\/\/doi.org\/10.4161\/auto.5905","journal-title":"Autophagy"},{"key":"10539_CR61","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","volume":"14","author":"TN Stitt","year":"2004","unstructured":"Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO et al (2004) The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14:395\u2013403. https:\/\/doi.org\/10.1016\/S1097-2765(04)00211-4","journal-title":"Mol Cell"},{"key":"10539_CR62","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-981-13-1435-3_6","volume-title":"Muscle atrophy","author":"LT Timmer","year":"2018","unstructured":"Timmer LT, Hoogaars WMH, Jaspers RT (2018) The role of IGF-1 signaling in skeletal muscle atrophy. In: Xiao J (ed) Muscle atrophy, vol 1088. Singapore, Springer Singapore, pp 109\u201337. https:\/\/doi.org\/10.1007\/978-981-13-1435-3_6"},{"key":"10539_CR63","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrm3507","volume":"14","author":"A Eijkelenboom","year":"2013","unstructured":"Eijkelenboom A, Burgering BMT (2013) FOXOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol 14:83\u201397. https:\/\/doi.org\/10.1038\/nrm3507","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10539_CR64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","volume":"5","author":"E Birben","year":"2012","unstructured":"Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O (2012) Oxidative stress and antioxidant defense. World Allergy Organ J 5:9\u201319. https:\/\/doi.org\/10.1097\/WOX.0b013e3182439613","journal-title":"World Allergy Organ J"},{"key":"10539_CR65","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1164\/rccm.200301-147OC","volume":"169","author":"R Bowers","year":"2004","unstructured":"Bowers R, Cool C, Murphy RC, Tuder RM, Hopken MW, Flores SC et al (2004) Oxidative stress in severe pulmonary hypertension. Am J Respir Crit Care Med 169:764\u2013769. https:\/\/doi.org\/10.1164\/rccm.200301-147OC","journal-title":"Am J Respir Crit Care Med"},{"key":"10539_CR66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40885-024-00270-z","volume":"30","author":"LB Leite","year":"2024","unstructured":"Leite LB, Soares LL, Portes AMO, Soares TI, Da Silva BAF, Dias TR et al (2024) Combined physical training protects the left ventricle from structural and functional damages in experimental pulmonary arterial hypertension. Clin Hypertens 30:12. https:\/\/doi.org\/10.1186\/s40885-024-00270-z","journal-title":"Clin Hypertens"},{"key":"10539_CR67","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1086\/674764","volume":"3","author":"GS Reis","year":"2013","unstructured":"Reis GS, Augusto VS, Silveira APC, Jord\u00e3o AA, Baddini-Martinez J, Poli Neto O et al (2013) Oxidative-stress biomarkers in patients with pulmonary hypertension. Pulm Circ 3:856\u2013861. https:\/\/doi.org\/10.1086\/674764","journal-title":"Pulm Circ"},{"key":"10539_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3795320","volume":"2019","author":"A Smukowska-Gorynia","year":"2019","unstructured":"Smukowska-Gorynia A, Rzymski P, Marcinkowska J, Poniedzia\u0142ek B, Komosa A, Cieslewicz A et al (2019) Prognostic value of oxidative stress markers in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension. Oxid Med Cell Longev 2019:1\u201310. https:\/\/doi.org\/10.1155\/2019\/3795320","journal-title":"Oxid Med Cell Longev"},{"key":"10539_CR69","doi-asserted-by":"publisher","first-page":"122128","DOI":"10.1016\/j.lfs.2023.122128","volume":"332","author":"LL Soares","year":"2023","unstructured":"Soares LL, Leite LB, Ervilha LOG, Pelozin BRA, Pereira NP, Da Silva BAF et al (2023) Resistance exercise training benefits pulmonary, cardiac, and muscular structure and function in rats with stable pulmonary artery hypertension. Life Sci 332:122128. https:\/\/doi.org\/10.1016\/j.lfs.2023.122128","journal-title":"Life Sci"},{"key":"10539_CR70","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1183\/09031936.00013309","volume":"34","author":"S Spiekermann","year":"2009","unstructured":"Spiekermann S, Schenk K, Hoeper MM (2009) Increased xanthine oxidase activity in idiopathic pulmonary arterial hypertension. Eur Respir J 34:276\u2013276. https:\/\/doi.org\/10.1183\/09031936.00013309","journal-title":"Eur Respir J"},{"key":"10539_CR71","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/thx.2004.037531","volume":"60","author":"C Koechlin","year":"2005","unstructured":"Koechlin C, Maltais F, Saey D, Michaud A, LeBlanc P, Hayot M et al (2005) Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease. Thorax 60:834\u2013841. https:\/\/doi.org\/10.1136\/thx.2004.037531","journal-title":"Thorax"},{"key":"10539_CR72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.21693\/1933-088X-23.1.21","volume":"23","author":"S Malenfant","year":"2024","unstructured":"Malenfant S, Potus F, Bonnet S, Provencher S (2024) Skeletal muscle structural and functional impairments as important peripheral exercise intolerance determinants in pulmonary arterial hypertension. Adv Pulmon Hypert 23:21\u20136. https:\/\/doi.org\/10.21693\/1933-088X-23.1.21","journal-title":"Adv Pulmon Hypert"},{"key":"10539_CR73","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1183\/13993003.02052-2014","volume":"46","author":"E Manders","year":"2015","unstructured":"Manders E, Rain S, Bogaard H-J, Handoko ML, Stienen GJM, Vonk-Noordegraaf A et al (2015) The striated muscles in pulmonary arterial hypertension: adaptations beyond the right ventricle. Eur Respir J 46:832\u2013842. https:\/\/doi.org\/10.1183\/13993003.02052-2014","journal-title":"Eur Respir J"},{"key":"10539_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2045894018768290","volume":"8","author":"S Sithamparanathan","year":"2018","unstructured":"Sithamparanathan S, Rocha MC, Parikh JD, Rygiel KA, Falkous G, Grady JP et al (2018) Skeletal muscle mitochondrial oxidative phosphorylation function in idiopathic pulmonary arterial hypertension: in vivo and in vitro study. Pulm Circ 8:1\u20135. https:\/\/doi.org\/10.1177\/2045894018768290","journal-title":"Pulm Circ"},{"key":"10539_CR75","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","volume":"21","author":"MJ Morgan","year":"2011","unstructured":"Morgan MJ, Liu Z (2011) Crosstalk of reactive oxygen species and NF-\u03baB signaling. Cell Res 21:103\u2013115. https:\/\/doi.org\/10.1038\/cr.2010.178","journal-title":"Cell Res"},{"key":"10539_CR76","doi-asserted-by":"publisher","first-page":"115664","DOI":"10.1016\/j.bcp.2023.115664","volume":"214","author":"H Zhang","year":"2023","unstructured":"Zhang H, Qi G, Wang K, Yang J, Shen Y, Yang X et al (2023) Oxidative stress: roles in skeletal muscle atrophy. Biochem Pharmacol 214:115664. https:\/\/doi.org\/10.1016\/j.bcp.2023.115664","journal-title":"Biochem Pharmacol"},{"key":"10539_CR77","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1089\/ars.2011.3973","volume":"15","author":"SK Powers","year":"2011","unstructured":"Powers SK, Smuder AJ, Criswell DS (2011) Mechanistic links between oxidative stress and disuse muscle atrophy. Antioxid Redox Signal 15:2519\u20132528. https:\/\/doi.org\/10.1089\/ars.2011.3973","journal-title":"Antioxid Redox Signal"},{"key":"10539_CR78","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1177\/154405910708600902","volume":"86","author":"JF Schindler","year":"2007","unstructured":"Schindler JF, Monahan JB, Smith WG (2007) p38 pathway kinases as anti-inflammatory drug targets. J Dent Res 86:800\u2013811. https:\/\/doi.org\/10.1177\/154405910708600902","journal-title":"J Dent Res"},{"key":"10539_CR79","doi-asserted-by":"publisher","unstructured":"Chatterjee S (2016) Oxidative stress, inflammation, and disease Oxidative stress and biomaterials. Elsevier. pp. 35 58 https:\/\/doi.org\/10.1016\/B978-0-12-803269-5.00002-4","DOI":"10.1016\/B978-0-12-803269-5.00002-4"},{"key":"10539_CR80","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","volume":"122","author":"SJ Forrester","year":"2018","unstructured":"Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q, Griendling KK (2018) Reactive oxygen species in metabolic and inflammatory signaling. Circ Res 122:877\u2013902. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311401","journal-title":"Circ Res"},{"key":"10539_CR81","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ (2018) AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol 19:121\u2013135. https:\/\/doi.org\/10.1038\/nrm.2017.95","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10539_CR82","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","volume":"24","author":"GR Steinberg","year":"2023","unstructured":"Steinberg GR, Hardie DG (2023) New insights into activation and function of the AMPK. Nat Rev Mol Cell Biol 24:255\u2013272. https:\/\/doi.org\/10.1038\/s41580-022-00547-x","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10539_CR83","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1152\/physiol.00050.2013","volume":"29","author":"DG Hardie","year":"2014","unstructured":"Hardie DG, Ashford MLJ (2014) AMPK: regulating energy balance at the cellular and whole body levels. Physiology 29:99\u2013107. https:\/\/doi.org\/10.1152\/physiol.00050.2013","journal-title":"Physiology"},{"key":"10539_CR84","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1172\/JCI120847","volume":"128","author":"MK Culley","year":"2018","unstructured":"Culley MK, Chan SY (2018) Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains. J Clin Invest 128:3704\u20133715. https:\/\/doi.org\/10.1172\/JCI120847","journal-title":"J Clin Invest"},{"key":"10539_CR85","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.2697","volume":"221","author":"D Glick","year":"2010","unstructured":"Glick D, Barth S, Macleod KF (2010) Autophagy: cellular and molecular mechanisms. J Pathol 221:3\u201312. https:\/\/doi.org\/10.1002\/path.2697","journal-title":"J Pathol"},{"key":"10539_CR86","doi-asserted-by":"publisher","first-page":"119753","DOI":"10.1016\/j.bbamcr.2024.119753","volume":"1871","author":"S Raza","year":"2024","unstructured":"Raza S (2024) Autophagy and metabolic aging: current understanding and future applications. Biochimica et Biophys Acta BBA - Mol Cell Res 1871:119753. https:\/\/doi.org\/10.1016\/j.bbamcr.2024.119753","journal-title":"Biochimica et Biophys Acta BBA - Mol Cell Res"},{"key":"10539_CR87","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41576-022-00562-w","volume":"24","author":"H Yamamoto","year":"2023","unstructured":"Yamamoto H, Zhang S, Mizushima N (2023) Autophagy genes in biology and disease. Nat Rev Genet 24:382\u2013400. https:\/\/doi.org\/10.1038\/s41576-022-00562-w","journal-title":"Nat Rev Genet"},{"key":"10539_CR88","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10495-018-1477-4","volume":"23","author":"R Chen","year":"2018","unstructured":"Chen R, Jiang M, Li B, Zhong W, Wang Z, Yuan W et al (2018) The role of autophagy in pulmonary hypertension: a double-edge sword. Apoptosis 23:459\u2013469. https:\/\/doi.org\/10.1007\/s10495-018-1477-4","journal-title":"Apoptosis"},{"key":"10539_CR89","doi-asserted-by":"publisher","first-page":"1206406","DOI":"10.3389\/fimmu.2023.1206406","volume":"14","author":"M Mao","year":"2023","unstructured":"Mao M, Song S, Li X, Lu J, Li J, Zhao W et al (2023) Advances in epigenetic modifications of autophagic process in pulmonary hypertension. Front Immunol 14:1206406. https:\/\/doi.org\/10.3389\/fimmu.2023.1206406","journal-title":"Front Immunol"},{"key":"10539_CR90","doi-asserted-by":"publisher","first-page":"16755","DOI":"10.1002\/jcp.28531","volume":"234","author":"C Zhang","year":"2019","unstructured":"Zhang C, Zhao F, Xu S, Liu J, Xing X, Yang J (2019) Autophagy in pulmonary hypertension: emerging roles and therapeutic implications. J Cell Physiol 234:16755\u201316767. https:\/\/doi.org\/10.1002\/jcp.28531","journal-title":"J Cell Physiol"},{"key":"10539_CR91","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/cdd.2010.191","volume":"18","author":"R Kang","year":"2011","unstructured":"Kang R, Zeh HJ, Lotze MT, Tang D (2011) The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 18:571\u2013580. https:\/\/doi.org\/10.1038\/cdd.2010.191","journal-title":"Cell Death Differ"},{"key":"10539_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/849541","volume":"2012","author":"A Salminen","year":"2012","unstructured":"Salminen A, Hyttinen JMT, Kauppinen A, Kaarniranta K (2012) Context-dependent regulation of autophagy by IKK-NF- \u03ba B signaling: impact on the aging process. Int J Cell Biol 2012:1\u201315. https:\/\/doi.org\/10.1155\/2012\/849541","journal-title":"Int J Cell Biol"},{"key":"10539_CR93","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41419-020-2399-y","volume":"11","author":"D Verzella","year":"2020","unstructured":"Verzella D, Pescatore A, Capece D, Vecchiotti D, Ursini MV, Franzoso G et al (2020) Life, death, and autophagy in cancer: NF-\u03baB turns up everywhere. Cell Death Dis 11:210. https:\/\/doi.org\/10.1038\/s41419-020-2399-y","journal-title":"Cell Death Dis"},{"key":"10539_CR94","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/ncb2797","volume":"15","author":"VY Nazarko","year":"2013","unstructured":"Nazarko VY, Zhong Q (2013) ULK1 targets Beclin-1 in autophagy. Nat Cell Biol 15:727\u2013728. https:\/\/doi.org\/10.1038\/ncb2797","journal-title":"Nat Cell Biol"},{"key":"10539_CR95","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.egyr.2020.11.145","volume":"6","author":"SM Figueiredo","year":"2020","unstructured":"Figueiredo SM, Sousa FOC, Lopes MAG, Quinta-Ferreira RM, Quinta-Ferreira ME (2020) Effect of oxygen levels in cellular activity. Energy Rep 6:286\u2013291. https:\/\/doi.org\/10.1016\/j.egyr.2020.11.145","journal-title":"Energy Rep"},{"key":"10539_CR96","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/cdd.2008.12","volume":"15","author":"A Weidemann","year":"2008","unstructured":"Weidemann A, Johnson RS (2008) Biology of HIF-1\u03b1. Cell Death Differ 15:621\u2013627. https:\/\/doi.org\/10.1038\/cdd.2008.12","journal-title":"Cell Death Differ"},{"key":"10539_CR97","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ceb.2009.11.015","volume":"22","author":"NM Mazure","year":"2010","unstructured":"Mazure NM, Pouyss\u00e9gur J (2010) Hypoxia-induced autophagy: cell death or cell survival? Curr Opin Cell Biol 22:177\u2013180. https:\/\/doi.org\/10.1016\/j.ceb.2009.11.015","journal-title":"Curr Opin Cell Biol"},{"key":"10539_CR98","doi-asserted-by":"publisher","unstructured":"Huang J, Zhu X (2016) The molecular mechanisms of calpains action on skeletal muscle atrophy. Physiol Res 547\u201360. https:\/\/doi.org\/10.33549\/physiolres.933087","DOI":"10.33549\/physiolres.933087"},{"key":"10539_CR99","doi-asserted-by":"publisher","first-page":"884","DOI":"10.5551\/jat.RV17009","volume":"24","author":"H Abe","year":"2017","unstructured":"Abe H, Semba H, Takeda N (2017) The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases. J Atheroscler Thromb 24:884\u2013894. https:\/\/doi.org\/10.5551\/jat.RV17009","journal-title":"J Atheroscler Thromb"},{"key":"10539_CR100","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1054\/clnu.2001.0483","volume":"20","author":"AJ Wagenmakers","year":"2001","unstructured":"Wagenmakers AJ (2001) Muscle function in critically ill patients. Clin Nutr 20:451\u2013454. https:\/\/doi.org\/10.1054\/clnu.2001.0483","journal-title":"Clin Nutr"},{"key":"10539_CR101","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0378-4274(92)90208-2","volume":"64\u201365","author":"S Orrenius","year":"1992","unstructured":"Orrenius S, McCabe MJ, Nicotera P (1992) Ca2+-dependent mechanisms of cytotoxicity and programmed cell death. Toxicol Lett 64\u201365:357\u2013364. https:\/\/doi.org\/10.1016\/0378-4274(92)90208-2","journal-title":"Toxicol Lett"},{"key":"10539_CR102","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nrm1150","volume":"4","author":"S Orrenius","year":"2003","unstructured":"Orrenius S, Zhivotovsky B, Nicotera P (2003) Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 4:552\u2013565. https:\/\/doi.org\/10.1038\/nrm1150","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10539_CR103","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2613.2000.00169.x","volume":"81","author":"PW Vanderklish","year":"2000","unstructured":"Vanderklish PW, Bahr BA (2000) The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int J Exp Pathol 81:323\u2013339. https:\/\/doi.org\/10.1111\/j.1365-2613.2000.00169.x","journal-title":"Int J Exp Pathol"},{"key":"10539_CR104","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI29044","volume":"116","author":"YC Long","year":"2006","unstructured":"Long YC (2006) AMP-activated protein kinase signaling in metabolic regulation. J Clin Investig 116:1776\u20131783. https:\/\/doi.org\/10.1172\/JCI29044","journal-title":"J Clin Investig"},{"key":"10539_CR105","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.numecd.2014.10.005","volume":"25","author":"AM Marra","year":"2015","unstructured":"Marra AM, Arcopinto M, Bossone E, Ehlken N, Cittadini A, Gr\u00fcnig E (2015) Pulmonary arterial hypertension-related myopathy: an overview of current data and future perspectives. Nutr Metab Cardiovasc Dis 25:131\u2013139. https:\/\/doi.org\/10.1016\/j.numecd.2014.10.005","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10539_CR106","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","volume":"3","author":"J Kim","year":"2006","unstructured":"Kim J, Tchernyshyov I, Semenza GL, Dang CV (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3:177\u2013185. https:\/\/doi.org\/10.1016\/j.cmet.2006.02.002","journal-title":"Cell Metab"},{"key":"10539_CR107","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/01.RES.0000093984.48643.D7","volume":"93","author":"M Yamakawa","year":"2003","unstructured":"Yamakawa M, Liu LX, Date T, Belanger AJ, Vincent KA, Akita GY et al (2003) Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 93:664\u2013673. https:\/\/doi.org\/10.1161\/01.RES.0000093984.48643.D7","journal-title":"Circ Res"},{"key":"10539_CR108","doi-asserted-by":"publisher","first-page":"170094","DOI":"10.1183\/16000617.0094-2017","volume":"26","author":"SY Chan","year":"2017","unstructured":"Chan SY, Rubin LJ (2017) Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice. Eur Respir Rev 26:170094. https:\/\/doi.org\/10.1183\/16000617.0094-2017","journal-title":"Eur Respir Rev"},{"key":"10539_CR109","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/j.biocel.2013.05.016","volume":"45","author":"S Ciciliot","year":"2013","unstructured":"Ciciliot S, Rossi AC, Dyar KA, Blaauw B, Schiaffino S (2013) Muscle type and fiber type specificity in muscle wasting. Int J Biochem Cell Biol 45:2191\u20132199. https:\/\/doi.org\/10.1016\/j.biocel.2013.05.016","journal-title":"Int J Biochem Cell Biol"},{"key":"10539_CR110","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1152\/physrev.00031.2010","volume":"91","author":"S Schiaffino","year":"2011","unstructured":"Schiaffino S, Reggiani C (2011) Fiber types in mammalian skeletal muscles. Physiol Rev 91:1447\u20131531. https:\/\/doi.org\/10.1152\/physrev.00031.2010","journal-title":"Physiol Rev"},{"key":"10539_CR111","doi-asserted-by":"publisher","first-page":"S224","DOI":"10.1097\/RHU.0000000000001721","volume":"27","author":"IBP Borges","year":"2021","unstructured":"Borges IBP, De Oliveira DS, Marie SKN, Lenario AM, Oba-Shinjo SM, Shinjo SK (2021) Exercise training attenuates ubiquitin-proteasome pathway and increases the genes related to autophagy on the skeletal muscle of patients with inflammatory myopathies. J Clin Rheumatol 27:S224\u2013S231. https:\/\/doi.org\/10.1097\/RHU.0000000000001721","journal-title":"J Clin Rheumatol"},{"key":"10539_CR112","doi-asserted-by":"publisher","first-page":"e41701","DOI":"10.1371\/journal.pone.0041701","volume":"7","author":"TF Cunha","year":"2012","unstructured":"Cunha TF, Bacurau AVN, Moreira JBN, Paix\u00e3o NA, Campos JC, Ferreira JCB et al (2012) Exercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failure. PLoS ONE 7:e41701. https:\/\/doi.org\/10.1371\/journal.pone.0041701","journal-title":"PLoS ONE"},{"key":"10539_CR113","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nri3041","volume":"11","author":"M Gleeson","year":"2011","unstructured":"Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA (2011) The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 11:607\u2013615. https:\/\/doi.org\/10.1038\/nri3041","journal-title":"Nat Rev Immunol"},{"key":"10539_CR114","doi-asserted-by":"publisher","first-page":"114272","DOI":"10.1016\/j.physbeh.2023.114272","volume":"269","author":"M Khalafi","year":"2023","unstructured":"Khalafi M, Aria B, Symonds ME, Rosenkranz SK (2023) The effects of resistance training on myostatin and follistatin in adults: a systematic review and meta-analysis. Physiol Behav 269:114272. https:\/\/doi.org\/10.1016\/j.physbeh.2023.114272","journal-title":"Physiol Behav"},{"key":"10539_CR115","doi-asserted-by":"publisher","first-page":"C164","DOI":"10.1152\/ajpcell.00344.2021","volume":"322","author":"L Feng","year":"2022","unstructured":"Feng L, Li B, Xi Y, Cai M, Tian Z (2022) Aerobic exercise and resistance exercise alleviate skeletal muscle atrophy through IGF-1\/IGF-1R-PI3K\/Akt pathway in mice with myocardial infarction. Am J Physiol Cell Physiol 322:C164\u2013C176. https:\/\/doi.org\/10.1152\/ajpcell.00344.2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"10539_CR116","doi-asserted-by":"publisher","first-page":"583478","DOI":"10.3389\/fphys.2020.583478","volume":"11","author":"Z Zeng","year":"2020","unstructured":"Zeng Z, Liang J, Wu L, Zhang H, Lv J, Chen N (2020) Exercise-induced autophagy suppresses sarcopenia through Akt\/mTOR and Akt\/FoxO3a signal pathways and AMPK-mediated mitochondrial quality control. Front Physiol 11:583478. https:\/\/doi.org\/10.3389\/fphys.2020.583478","journal-title":"Front Physiol"},{"key":"10539_CR117","doi-asserted-by":"publisher","first-page":"117630","DOI":"10.1016\/j.lfs.2020.117630","volume":"252","author":"A Thirupathi","year":"2020","unstructured":"Thirupathi A, Pinho RA, Chang Y-Z (2020) Physical exercise: an inducer of positive oxidative stress in skeletal muscle aging. Life Sci 252:117630. https:\/\/doi.org\/10.1016\/j.lfs.2020.117630","journal-title":"Life Sci"},{"key":"10539_CR118","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1440-1681.2009.05310.x","volume":"37","author":"RM Murphy","year":"2010","unstructured":"Murphy RM (2010) Calpains, skeletal muscle function and exercise. Clin Exp Pharma Physio 37:385\u2013391. https:\/\/doi.org\/10.1111\/j.1440-1681.2009.05310.x","journal-title":"Clin Exp Pharma Physio"},{"key":"10539_CR119","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.freeradbiomed.2016.03.025","volume":"98","author":"R Qaisar","year":"2016","unstructured":"Qaisar R, Bhaskaran S, Van Remmen H (2016) Muscle fiber type diversification during exercise and regeneration. Free Radical Biol Med 98:56\u201367. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.03.025","journal-title":"Free Radical Biol Med"},{"key":"10539_CR120","doi-asserted-by":"publisher","first-page":"11818","DOI":"10.1038\/s41598-018-30365-1","volume":"8","author":"JC Campos","year":"2018","unstructured":"Campos JC, Baehr LM, Gomes KMS, Bechara LRG, Voltarelli VA, Bozi LHM et al (2018) Exercise prevents impaired autophagy and proteostasis in a model of neurogenic myopathy. Sci Rep 8:11818. https:\/\/doi.org\/10.1038\/s41598-018-30365-1","journal-title":"Sci Rep"},{"key":"10539_CR121","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/HCR.0000000000000443","volume":"39","author":"T Koudstaal","year":"2019","unstructured":"Koudstaal T, Wapenaar M, Van Ranst D, Beesems R, Van Den Toorn L, Van Den Bosch A et al (2019) The effects of a 10-wk outpatient pulmonary rehabilitation program on exercise performance, muscle strength, soluble biomarkers, and quality of life in patients with pulmonary hypertension. J Cardiopulm Rehabil Prev 39:397\u2013402. https:\/\/doi.org\/10.1097\/HCR.0000000000000443","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"10539_CR122","doi-asserted-by":"publisher","first-page":"118298","DOI":"10.1016\/j.lfs.2020.118298","volume":"261","author":"JS Vieira","year":"2020","unstructured":"Vieira JS, Cunha TF, Paix\u00e3o NA, Dourado PM, Carrascoza LS, Bacurau AVN et al (2020) Exercise intolerance establishment in pulmonary hypertension: preventive effect of aerobic exercise training. Life Sci 261:118298. https:\/\/doi.org\/10.1016\/j.lfs.2020.118298","journal-title":"Life Sci"},{"key":"10539_CR123","doi-asserted-by":"publisher","first-page":"1206484","DOI":"10.3389\/fphys.2023.1206484","volume":"14","author":"FR Drummond","year":"2023","unstructured":"Drummond FR, Soares LL, Leal TF, Leite LB, Rezende LMT, Fidelis MR et al (2023) Effects of voluntary running on the skeletal muscle of rats with pulmonary artery hypertension. Front Physiol 14:1206484. https:\/\/doi.org\/10.3389\/fphys.2023.1206484","journal-title":"Front Physiol"},{"key":"10539_CR124","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1080\/13813455.2020.1769679","volume":"128","author":"CU Becker","year":"2022","unstructured":"Becker CU, Sart\u00f3rio CL, Campos-Carraro C, Siqueira R, Colombo R, Zimmer A et al (2022) Exercise training decreases oxidative stress in skeletal muscle of rats with pulmonary arterial hypertension. Arch Physiol Biochem 128:1330\u20131338. https:\/\/doi.org\/10.1080\/13813455.2020.1769679","journal-title":"Arch Physiol Biochem"},{"key":"10539_CR125","doi-asserted-by":"publisher","first-page":"R197","DOI":"10.1152\/ajpregu.00358.2016","volume":"312","author":"MB Brown","year":"2017","unstructured":"Brown MB, Neves E, Long G, Graber J, Gladish B, Wiseman A et al (2017) High-intensity interval training, but not continuous training, reverses right ventricular hypertrophy and dysfunction in a rat model of pulmonary hypertension. Am J Physiol Regul Integr Comp Physiol 312:R197-210. https:\/\/doi.org\/10.1152\/ajpregu.00358.2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10539_CR126","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1249\/MSS.0000000000000696","volume":"47","author":"S Malenfant","year":"2015","unstructured":"Malenfant S, Potus F, Mainguy V, Leblanc E, Malenfant M, Ribeiro F et al (2015) Impaired skeletal muscle oxygenation and exercise tolerance in pulmonary hypertension. Med Sci Sports Exerc 47:2273\u20132282. https:\/\/doi.org\/10.1249\/MSS.0000000000000696","journal-title":"Med Sci Sports Exerc"},{"key":"10539_CR127","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1183\/0903193","volume":"34","author":"FS De Man","year":"2009","unstructured":"De Man FS, Handoko ML, Groepenhoff H, Van T, Hul AJ, Abbink J, Koppers RJH et al (2009) Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 34:669\u201375. https:\/\/doi.org\/10.1183\/0903193","journal-title":"Eur Respir J"},{"key":"10539_CR128","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.jacc.2011.06.025","volume":"58","author":"F Esposito","year":"2011","unstructured":"Esposito F, Reese V, Shabetai R, Wagner PD, Richardson RS (2011) Isolated quadriceps training increases maximal exercise capacity in chronic heart failure. J Am Coll Cardiol 58:1353\u20131362. https:\/\/doi.org\/10.1016\/j.jacc.2011.06.025","journal-title":"J Am Coll Cardiol"},{"key":"10539_CR129","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10974-022-09636-y","volume":"44","author":"PD Wagner","year":"2023","unstructured":"Wagner PD (2023) Determinants of maximal oxygen consumption. J Muscle Res Cell Motil 44:73\u201388. https:\/\/doi.org\/10.1007\/s10974-022-09636-y","journal-title":"J Muscle Res Cell Motil"},{"key":"10539_CR130","first-page":"10","volume":"28","author":"PD Wagner","year":"2000","unstructured":"Wagner PD (2000) New ideas on limitations to VO\u2082max. Exerc Sport Sci Rev 28:10\u201314","journal-title":"Exerc Sport Sci Rev"},{"key":"10539_CR131","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2165\/00007256-199111030-00001","volume":"11","author":"PD Wagner","year":"1991","unstructured":"Wagner PD (1991) Central and peripheral aspects of oxygen transport and adaptations with exercise. Sports Med 11:133\u2013142. https:\/\/doi.org\/10.2165\/00007256-199111030-00001","journal-title":"Sports Med"},{"key":"10539_CR132","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1249\/00005768-199201000-00010","volume":"24","author":"PD Wagner","year":"1992","unstructured":"Wagner PD (1992) Gas exchange and peripheral diffusion limitation. Med Sci Sports Exerc 24:54\u201358","journal-title":"Med Sci Sports Exerc"},{"key":"10539_CR133","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s11325-020-02286-9","volume":"25","author":"H Atef","year":"2021","unstructured":"Atef H, Abdeen H (2021) Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension. Sleep Breathing 25:1953\u20131960. https:\/\/doi.org\/10.1007\/s11325-020-02286-9","journal-title":"Sleep Breathing"},{"key":"10539_CR134","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.hrtlng.2020.04.006","volume":"49","author":"BC Y\u0131lmaz","year":"2020","unstructured":"Y\u0131lmaz BC, G\u00fc\u00e7l\u00fc MB, Kele\u015f MN, Ta\u00e7oy GA, \u00c7engel A (2020) Effects of upper extremity aerobic exercise training on oxygen consumption, exercise capacity, dyspnea and quality of life in patients with pulmonary arterial hypertension. Heart Lung 49:564\u2013571. https:\/\/doi.org\/10.1016\/j.hrtlng.2020.04.006","journal-title":"Heart Lung"},{"key":"10539_CR135","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.amjcard.2023.06.097","volume":"203","author":"BO Kahraman","year":"2023","unstructured":"Kahraman BO, Tanriverdi A, Savci S, Odaman H, Akdeniz B, Sevinc C et al (2023) Effects of inspiratory muscle training in patients with pulmonary hypertension. Am J Cardiol 203:406\u2013413. https:\/\/doi.org\/10.1016\/j.amjcard.2023.06.097","journal-title":"Am J Cardiol"},{"key":"10539_CR136","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.hlc.2020.06.006","volume":"30","author":"D Tran","year":"2021","unstructured":"Tran D, Munoz P, Lau EMT, Alison JA, Brown M, Zheng Y et al (2021) Inspiratory muscle training improves inspiratory muscle strength and functional exercise capacity in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a pilot randomised controlled study. Heart Lung Circ 30:388\u2013395. https:\/\/doi.org\/10.1016\/j.hlc.2020.06.006","journal-title":"Heart Lung Circ"},{"key":"10539_CR137","doi-asserted-by":"publisher","first-page":"e12069","DOI":"10.1002\/pul2.12069","volume":"12","author":"KSW Chia","year":"2022","unstructured":"Chia KSW, Shiner CT, Brown K, Holloway CJ, Moreyra C, Bart N et al (2022) The exercise in pulmonary arterial hypertension (ExPAH) study: a randomized controlled pilot of exercise training and multidisciplinary rehabilitation in pulmonary arterial hypertension. Pulm Circ 12:e12069. https:\/\/doi.org\/10.1002\/pul2.12069","journal-title":"Pulm Circ"},{"key":"10539_CR138","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1093\/eurheartj\/ehaa696","volume":"42","author":"E Gr\u00fcnig","year":"2021","unstructured":"Gr\u00fcnig E, MacKenzie A, Peacock AJ, Eichstaedt CA, Benjamin N, Nechwatal R et al (2021) Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial. Eur Heart J 42:2284\u20132295. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa696","journal-title":"Eur Heart J"},{"key":"10539_CR139","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000512316","volume":"100","author":"C Nagel","year":"2021","unstructured":"Nagel C, Benjamin N, Egenlauf B, Eichstaedt CA, Fischer C, Palevi\u010di\u016bt\u0117 E et al (2021) Effect of supervised training therapy on pulmonary arterial compliance and stroke volume in severe pulmonary arterial hypertension and inoperable or persistent chronic thromboembolic pulmonary hypertension. Respiration 100:369\u2013378. https:\/\/doi.org\/10.1159\/000512316","journal-title":"Respiration"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10539-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-025-10539-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10539-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T20:04:36Z","timestamp":1763150676000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-025-10539-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":139,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10539"],"URL":"https:\/\/doi.org\/10.1007\/s10741-025-10539-6","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"10 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}